Average Co-Inventor Count = 8.19
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (31 from 1,153 patents)
2. Vertex Pharmaceuticals Incoropated (1 from 1 patent)
32 patents:
1. 12384762 - Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
2. 12168009 - Modulators of cystic fibrosis transmembrane conductance regulator
3. 11453655 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
4. 11426407 - Modulators of cystic fibrosis transmembrane conductance regulator
5. 11186566 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
6. 10793547 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
7. 10758534 - Modulators of cystic fibrosis transmembrane conductance regulator
8. 10570115 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
9. 10258624 - Modulators of cystic fibrosis transmembrane conductance regulator
10. 9782408 - Modulators of cystic fibrosis transmembrane conductance regulator
11. 9630956 - Compounds useful as inhibitors of ATR kinase
12. 9181273 - Morpholine-spirocyclic piperidine amides as modulators of ion channels
13. 8883781 - Thienopyrimidines useful as modulators of ion channels
14. 8841483 - Compositions useful as inhibitors of voltage-gated sodium channels
15. 8828996 - Morpholine-spirocyclic piperidine amides as modulators of ion channels